Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

NCT06397963 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
18
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Grit Biotechnology

Collaborators